Advertisement

The Interventional Pharmacoeconomic Toolbox Panel Discussion

First International Summit on Interventional Pharmacoeconomics

Advertisement


Related Videos

David A. Hyman, MD, JD, on Inclusive Shared Savings

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement



Jan
22
Today In Oncology
Patient-Reported Outcomes With Triplet Therapy for Newly Diagnosed Multiple Myeloma
Surgical Intervention May Offer Survival Advantage for Certain Patients With Metastatic Breast Cancer
Do Adult-Onset Cancer Survivors Have a Higher Risk of Developing a Subsequent Malignancy
Adjuvant Gefitinib vs Vinorelbine/Cisplatin in Stage II–IIIA EGFR-Mutant NSCLC
Study Finds Inflammation Due to Androgen-Deprivation Therapy May Contribute to Fatigue, Other Side Effects in Men With Prostate Cancer
View More 
Advertisement
© 2021 HSP News Service, L.L.C.
Designed by Harborside